AGTC to Present Preclinical Research Supporting Gene

GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical-stage biotechnology company focused on the development of an adeno-associated virus (AAV)-based drug Gens is concentrating therapies to treat rare and debilitating diseases with an initial focus on inherited retinal disorders, preclinical data announced today, presented at … اقرأ المزيد